Top

Optie A:

Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
Optie B:

Deel de link per e-mail
Link delen

vorige artikel Talking About Death or Suicide: Prevalence and ...

volgende artikel Sleep Problems and Their Relationship to Malada...

Tip

Swipe om te navigeren naar een ander artikel

17-05-2017 | S.I. : Autism Inpatient Collection - Studying the Severely Affected | Uitgave 11/2018

Characterization of Medication Use in a Multicenter Sample of Pediatric Inpatients with Autism Spectrum Disorder

Tijdschrift:: Journal of Autism and Developmental Disorders > Uitgave 11/2018

Auteurs:: Logan K. Wink, Ernest V. Pedapati, Ryan Adams, Craig A. Erickson, Kahsi A. Pedersen, Eric M. Morrow, Desmond Kaplan, Matthew Siegel, for the Autism and Developmental Disorders Inpatient Research Collaborative (ADDIRC)

Extra’s

» Toegang tot de volledige tekst krijgen

Belangrijke opmerkingen

Electronic supplementary material

The online version of this article (doi:10.1007/s10803-017-3153-x) contains supplementary material, which is available to authorized users.

The members of ADDIRC are listed in Acknowledgments section.

Abstract

Nearly 11% of youth with Autism Spectrum Disorder (ASD) undergo psychiatric hospitalization, and 65% are treated with psychotropic medication. Here we characterize psychotropic medication usage in subjects enrolled in the Autism Inpatient Collection. Participant psychotropic medication usage rates topped 90% at admission and discharge, though there was a decline at 2-month follow-up. Antipsychotics, ADHD medications, and sleep aids were the most commonly reported classes of medications. The impact of age, gender, and non-verbal IQ on medication usage rates was minimal, though age and IQ may play a role in prescribing practices. Future work is indicated to explore medication usage trends, the impact of clinical factors on medication use rates, and the safety of psychotropic medications in youth with ASD.

Log in om toegang te krijgen

Hier inloggen

Met onderstaand(e) abonnement(en) heeft u direct toegang:

BSL Psychologie Totaal

Met BSL Psychologie Totaal blijft u als professional steeds op de hoogte van de nieuwste ontwikkelingen binnen uw vak. Met het online abonnement heeft u toegang tot een groot aantal boeken, protocollen, vaktijdschriften en e-learnings op het gebied van psychologie en psychiatrie. Zo kunt u op uw gemak en wanneer het u het beste uitkomt verdiepen in uw vakgebied.

Meer informatie

Supplementary material 1 (DOCX 12 KB)

10803_2017_3153_MOESM1_ESM.docx

Aman, M. G., Singh, N. N., Stewart, A. W., & Field, C. J. (1985). The aberrant behavior checklist: A behavior rating scale for the assessment of treatment effects. American Journal of Mental Deficiency, 5, 485–491.

Christensen, D. L. (2016). Prevalence and characteristics of autism spectrum disorder among children aged 8 years- autism developmental disabilities monitoring network. Surveillance Summaries 65.

Erickson, C. A., Posey, D. J., Stigler, K. A., & McDougle, C. J. (2007). Pharmacologic treatment of autism and related disorders. Pediatric Annals, 36, 575–585. CrossRefPubMed

Fitzpatrick, S. E., Srivorakiat, L., Wink, L. K., Pedapati, E. V., & Erickson, C. A. (2016). Aggression in autism spectrum disorder: Presentation and treatment options. Neuropsychiatric Disease and Treatment, 12, 1525–1538. doi: 10.2147/NDT.S84585. CrossRefPubMedPubMedCentral

King, B. H., et al. (2009). Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: Citalopram ineffective in children with autism. Archives of General Psychiatry, 66, 583–590. doi: 10.1001/archgenpsychiatry.2009.30. CrossRefPubMedPubMedCentral

Lord, C., Rutter, M., DiLavore, P., Risis, S., Gotham, K., & Bishop, S. (2012). Autism diagnostic observation schedule, second edition (ADOS-2). Torrance: Western Psychological Services.

Mandell, D. S. (2008). Psychiatric hospitalization among children with autism spectrum disorders. Journal of Autism and Developmental Disorders, 38, 1059–1065. doi: 10.1007/s10803-007-0481-2. CrossRefPubMed

Marcus, R. N., et al. (2009). A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 48, 1110–1119. doi: 10.1097/CHI.0b013e3181b76658. CrossRefPubMedPubMedCentral

McCracken, J. T., et al. (2002). Risperidone in children with autism and serious behavioral problems. The New England Journal of Medicine, 347, 314–321. CrossRefPubMed

McElhanon, B. O., McCracken, C., Karpen, S., & Sharp, W. G. (2014). Gastrointestinal symptoms in autism spectrum disorder: A meta-analysis. Pediatrics, 133, 872–883. doi: 10.1542/peds.2013-3995. CrossRefPubMed

McGuire, K., et al. (2015). Psychiatric hospitalization of children with autism or intellectual disability: Consensus statements on best practices. Journal of the American Academy of Child and Adolescent Psychiatry, 54, 969–971. doi: 10.1016/j.jaac.2015.08.017. CrossRefPubMedPubMedCentral

Molloy, C. A., & Manning-Courtney, P. (2003). Prevalence of chronic gastrointestinal symptoms in children with autism and autistic spectrum disorders. Autism, 7, 165–171. CrossRefPubMed

Owen, R., et al. (2009). Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics, 124, 1533–1540. doi: 10.1542/peds.2008-3782. CrossRefPubMed

Park, S. Y., et al. (2016). Antipsychotic use trends in youth with autism spectrum disorder and/or intellectual disability: A meta-analysis. Journal of the American Academy of Child and Adolescent Psychiatry, 55(456–468), e4. doi: 10.1016/j.jaac.2016.03.012. CrossRef

Politte, L. C., Henry, C. A., & McDougle, C. J. (2014). Psychopharmacological interventions in autism spectrum disorder. Harvard Review of Psychiatry, 22, 76–92. doi: 10.1097/HRP.0000000000000030. CrossRefPubMed

Research Units on Pediatric Psychopharmacology Autism Network (2005). Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Arch Gen Psychiatry 62, 1266–1274 doi: 10.1001/archpsyc.62.11.1266. CrossRef

Roid, G. H., Miller, L. J., Pomplun, M., Koch, C. (2013). Leiter international performance scale, 3rd Edition. Wood Dail, IL: Stoelting.

Rutter, M., Bailey, A., Lord, C. (2003). Social communication questionnaire. Torrance: Western Psychological Services.

Saldana, S. N., et al. (2014). Antipsychotic polypharmacy in children and adolescents at discharge from psychiatric hospitalization. Pharmacotherapy, 34, 836–844. doi: 10.1002/phar.1453. CrossRefPubMedPubMedCentral

Schubart, J. R., Camacho, F., & Leslie, D. (2014). Psychotropic medication trends among chidren and adolescents with autism psectrum disorder in the Medicaid program. Autism, 18, 631–637. CrossRefPubMed

Siegel, M., et al. (2015). The autism inpatient collection: methods and preliminary sample description. Molecular Autism, 6, 61. doi: 10.1186/s13229-015-0054-8. CrossRefPubMedPubMedCentral

Siegel, M., & Gabriels, R. L. (2014). Psychiatric hospital treatment of children with autism and serious behavioral disturbance. Child and Adolescent Psychiatric Clinics of North America, 23, 125–142. doi: 10.1016/j.chc.2013.07.004. CrossRefPubMed

Sparrow, S., Cicchetti, D., Balla, D.A. (2008). Vineland adaptive behaviors scales, 2nd Edition. Livonia: Pearson.

Spencer, D., et al. (2013). Psychotropic medication use and polypharmacy in children with autism spectrum disorders. Pediatrics, 132, 833–840. doi: 10.1542/peds.2012-3774. CrossRefPubMedPubMedCentral

Vasa, R. A., et al. (2014). A systematic review of treatments for anxiety in youth with autism spectrum disorders. Journal of Autism and Developmental Disorders, 44, 3215–3229. doi: 10.1007/s10803-014-2184-9. CrossRefPubMed

Wink, L. K., Erickson, C. A., & McDougle, C. J. (2010). Pharmacologic treatment of behavioral symptoms associated with autism and other pervasive developmental disorders. Current Treatment Options in Neurology, 12, 529–538. doi: 10.1007/s11940-010-0091-8. CrossRefPubMed

Titel: Characterization of Medication Use in a Multicenter Sample of Pediatric Inpatients with Autism Spectrum Disorder
Auteurs:: Logan K. Wink
Ernest V. Pedapati
Ryan Adams
Craig A. Erickson
Kahsi A. Pedersen
Eric M. Morrow
Desmond Kaplan
Matthew Siegel
for the Autism and Developmental Disorders Inpatient Research Collaborative (ADDIRC)
Publicatiedatum: 17-05-2017
DOI: https://doi.org/10.1007/s10803-017-3153-x
Uitgeverij: Springer US
Tijdschrift: Journal of Autism and Developmental Disorders
Uitgave 11/2018
Print ISSN: 0162-3257
Elektronisch ISSN: 1573-3432

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Tip

Swipe om te navigeren naar een ander artikel

Electronic supplementary material

Abstract

Log in om toegang te krijgen

Met onderstaand(e) abonnement(en) heeft u direct toegang:

BSL Psychologie Totaal

Andere artikelen Uitgave 11/2018

Differences of Symptom Distribution Across Adult Age in High Functioning Individuals on the Autism Spectrum Using Subscales of the Autism Spectrum Quotient

Development of the Emotion Dysregulation Inventory: A PROMIS®ing Method for Creating Sensitive and Unbiased Questionnaires for Autism Spectrum Disorder

Autism Diagnosis in the United Kingdom: Perspectives of Autistic Adults, Parents and Professionals

Verbal Ability and Psychiatric Symptoms in Clinically Referred Inpatient and Outpatient Youth with ASD

The Severe End of the Spectrum: Insights and Opportunities from the Autism Inpatient Collection (AIC)

Measuring Individual Differences in Cognitive, Affective, and Spontaneous Theory of Mind Among School-Aged Children with Autism Spectrum Disorder